Andera Partners — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.
BiotechHealthtechMedical Devices
Co-investorsQuan CapitalSofinnova PartnersAstellas Venture Management LLCEMBL VenturesFuture Planet CapitalAvlar BioVentures+1 more
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedBGVForbionFountain Healthcare PartnersHTGFPMV+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.